Literature DB >> 18572754

Distinct signature type I interferon responses are determined by the infecting virus and the target cell.

Ehtesham Baig1, Eleanor N Fish.   

Abstract

BACKGROUND: Type I interferons (IFN) include multiple IFN-alpha subtypes which exhibit considerable amino acid identity and activate the same cell-surface receptor. The promoter regions of the IFN-alpha genes, however, have different transcription factor binding sites, implying differential transcriptional activation. Evolutionary conservation of multiple subtypes may have resulted from external pressures associated with the crucial nature of an IFN response, namely that different viruses that are tropic for different target tissues determine the nature and extent of an IFN response, specifically the IFN-alpha subtype profile.
METHODS: Studies were undertaken to examine inducible IFN gene expression profiles in response to infection with single-stranded RNA viruses: Sendai virus (SeV), murine hepatitis virus (MHV-1) and coxsackie virus B3 (CVB3).
RESULTS: In vitro, distinct signature profiles of SeV and MHV-1-inducible gene expression for IFN-alpha2, IFN-alpha4 and IFN-alpha5 subtypes in L2 and L929 mouse fibroblast cells, in relation to the extent and kinetics of their induction, were identified. In vivo, whereas A/J mice are highly permissive for both MHV-1 and CVB3 infections and mount a poor IFN response, C57B1/6 mice are relatively resistant to both virus infections and mount a vigorous IFN response.
CONCLUSIONS: These data suggest that the infecting virus and the target cell type dictate the extent and signature of inducible type I IFN gene expression. The extent of IFN response to viral infection influences the subsequent biological outcome: a robust IFN response prescribes a level of resistance, whereas a poor IFN response contributes towards a permissive phenotype for infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572754

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  17 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Production and characterization of thirteen human type-I interferon-α subtypes.

Authors:  Srilalitha Kuruganti; Mary Ann Accavitti-Loper; Mark R Walter
Journal:  Protein Expr Purif       Date:  2014-08-20       Impact factor: 1.650

4.  Temporal and spatial resolution of type I and III interferon responses in vivo.

Authors:  Julia Elisabeth Pulverer; Ulfert Rand; Stefan Lienenklaus; Daniela Kugel; Natalia Zietara; Georg Kochs; Ronald Naumann; Siegfried Weiss; Peter Staeheli; Hansjörg Hauser; Mario Köster
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

5.  Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung.

Authors:  Luna Alammar Zaritsky; Alicia Dery; Wan Yee Leong; Lucio Gama; Janice E Clements
Journal:  J Interferon Cytokine Res       Date:  2012-10-10       Impact factor: 2.607

6.  MDA5 Induces a Stronger Interferon Response than RIG-I to GCRV Infection through a Mechanism Involving the Phosphorylation and Dimerization of IRF3 and IRF7 in CIK Cells.

Authors:  Quanyuan Wan; Chunrong Yang; Youliang Rao; Zhiwei Liao; Jianguo Su
Journal:  Front Immunol       Date:  2017-02-24       Impact factor: 7.561

Review 7.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

8.  Dissecting interferon-induced transcriptional programs in human peripheral blood cells.

Authors:  Simon J Waddell; Stephen J Popper; Kathleen H Rubins; Michael J Griffiths; Patrick O Brown; Michael Levin; David A Relman
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 9.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection.

Authors:  Lianna Li; Barbara Sherry
Journal:  Virology       Date:  2009-11-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.